Efficacy of combination therapy with mexiletine and a low dose of propranolol for premature ventricular arrhythmias.

Low dose quinidine-mexiletine combination therapy versus quinidine monotherapy for treatment of ventricular arrhythmias.

Mexiletine and propafenone: a comparative study of monotherapy, low, and full dose combination therapy.

Long-term treatment of ventricular arrhythmias with oral mexiletine.

Propafenone-mexiletine combination for the treatment of sustained ventricular tachycardia.

Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease.

Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction.

Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias.

Efficacy of moricizine in malignant ventricular arrhythmias.

The outcome of combination of low dose oral prednisolone with propranolol for the treatment of infantile haemangioma.

Propranolol, doxycycline and combination therapy for the treatment of rosacea.

Electrophysiological effects of the combination of mexiletine and flecainide in guinea-pig ventricular fibres.

Efficacy and safety of combination therapy of high-dose losartan and hydrochlorothiazide in patients with hypertension.

Epicardial propranolol administration for ventricular arrhythmias in dogs: matrix formulation and characterization.

Evaluation of Left Ventricular Endocardial Cardiac Resynchronization Therapy in a Non-responder with Ventricular Arrhythmias.

Treatment of Severe Alopecia Areata: Combination Therapy Using Systemic Cyclosporine A with Low Dose Corticosteroids.

Rare Association of Chiari's Network and Ventricular Arrhythmias in a Late Premature Neonate.

Dose effect of moricizine on suppression of ventricular arrhythmias.

Left ventricular markers of mortality and ventricular arrhythmias in heart failure patients with cardiac resynchronization therapy.

Mitral valve prolapse and electrolyte abnormality: a dangerous combination for ventricular arrhythmias.

Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma.

Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension.

Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade.

Mexiletine and disopyramide suppress ventricular premature contractions (VPC) irrespective of the relationship between the VPC and the underlying heart rate.

Effects of propranolol on premature action potentials in canine Purkinje and ventricular muscle.

Suggest Documents

Low dose quinidine-mexiletine combination therapy versus quinidine monotherapy for treatment of ventricular arrhythmias.

Mexiletine and propafenone: a comparative study of monotherapy, low, and full dose combination therapy.

Long-term treatment of ventricular arrhythmias with oral mexiletine.

Propafenone-mexiletine combination for the treatment of sustained ventricular tachycardia.

Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease.

Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction.

Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias.

Efficacy of moricizine in malignant ventricular arrhythmias.

The outcome of combination of low dose oral prednisolone with propranolol for the treatment of infantile haemangioma.

Propranolol, doxycycline and combination therapy for the treatment of rosacea.

Electrophysiological effects of the combination of mexiletine and flecainide in guinea-pig ventricular fibres.

Efficacy and safety of combination therapy of high-dose losartan and hydrochlorothiazide in patients with hypertension.

Epicardial propranolol administration for ventricular arrhythmias in dogs: matrix formulation and characterization.

Evaluation of Left Ventricular Endocardial Cardiac Resynchronization Therapy in a Non-responder with Ventricular Arrhythmias.

Treatment of Severe Alopecia Areata: Combination Therapy Using Systemic Cyclosporine A with Low Dose Corticosteroids.

Rare Association of Chiari's Network and Ventricular Arrhythmias in a Late Premature Neonate.

Dose effect of moricizine on suppression of ventricular arrhythmias.

Left ventricular markers of mortality and ventricular arrhythmias in heart failure patients with cardiac resynchronization therapy.

Mitral valve prolapse and electrolyte abnormality: a dangerous combination for ventricular arrhythmias.

Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma.

Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension.

Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade.

Mexiletine and disopyramide suppress ventricular premature contractions (VPC) irrespective of the relationship between the VPC and the underlying heart rate.

Effects of propranolol on premature action potentials in canine Purkinje and ventricular muscle.

Efficacy of combination therapy with mexiletine and a low dose of propranolol for premature ventricular arrhythmias.

Recommend Documents

Follow Us